Management of malignant lymphoma in the elderly an eortc retrospective evaluation

U. Tirelli

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

A retrospective Eortc study was carried out in order to evaluate the incidence, clinico-pathoiogical findings and outcome of non-Hodgkin lymphoma and Hodgkin's disease in patients 70 years of age or older. A significant proportion of non-Hodgkin lymphoma, mostly with high-intermediate grade of malignancy occurs in these patients. Aggressive treatment, in particular chemotherapy with 3 drugs or more administered to elderly patients 70 years or older, median age 77 years, is associated with significant lethal and severe toxicity. Prospective randomized studies are clearly needed in order to evaluate the activity and the toxicity of intensive chemotherapy regimens specifically devised for patients aged 70 years or older with unfavourable non-Hodgkin lymphoma. Hodgkin's disease is unfrequently (5% seen in patients 70 years of age or older. Mixed cellularity, B symptoms and stage III and IV account for 50, 47 and 47% of the cases respectively. Aggressive treatment is not associated with an increased lethal and severe toxicity compared with conservative treatment although 1 patient died of bone marrow toxicity after MOPP. Survival of patients 70 years or more with Hodgkin's disease seen in 1984 seems shorter than that in younger patients, especially due to high incidence of unfavourable prognostic factors, such as B symptoms and advanced stages.

Original languageEnglish
Pages (from-to)199-201
Number of pages3
JournalActa Oncologica
Volume28
Issue number2
DOIs
Publication statusPublished - 1989

Fingerprint

Lymphoma
Hodgkin Disease
Non-Hodgkin's Lymphoma
Drug Therapy
Incidence
Retrospective Studies
Bone Marrow
Prospective Studies
Survival
Therapeutics
Pharmaceutical Preparations
Neoplasms

Keywords

  • Hodgkin's disease
  • Non-Hodgkin lymphoma
  • Old patients

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Hematology

Cite this

Management of malignant lymphoma in the elderly an eortc retrospective evaluation. / Tirelli, U.

In: Acta Oncologica, Vol. 28, No. 2, 1989, p. 199-201.

Research output: Contribution to journalArticle

@article{4d2e8f36209b4884b1a98bc67ba359ab,
title = "Management of malignant lymphoma in the elderly an eortc retrospective evaluation",
abstract = "A retrospective Eortc study was carried out in order to evaluate the incidence, clinico-pathoiogical findings and outcome of non-Hodgkin lymphoma and Hodgkin's disease in patients 70 years of age or older. A significant proportion of non-Hodgkin lymphoma, mostly with high-intermediate grade of malignancy occurs in these patients. Aggressive treatment, in particular chemotherapy with 3 drugs or more administered to elderly patients 70 years or older, median age 77 years, is associated with significant lethal and severe toxicity. Prospective randomized studies are clearly needed in order to evaluate the activity and the toxicity of intensive chemotherapy regimens specifically devised for patients aged 70 years or older with unfavourable non-Hodgkin lymphoma. Hodgkin's disease is unfrequently (5{\%} seen in patients 70 years of age or older. Mixed cellularity, B symptoms and stage III and IV account for 50, 47 and 47{\%} of the cases respectively. Aggressive treatment is not associated with an increased lethal and severe toxicity compared with conservative treatment although 1 patient died of bone marrow toxicity after MOPP. Survival of patients 70 years or more with Hodgkin's disease seen in 1984 seems shorter than that in younger patients, especially due to high incidence of unfavourable prognostic factors, such as B symptoms and advanced stages.",
keywords = "Hodgkin's disease, Non-Hodgkin lymphoma, Old patients",
author = "U. Tirelli",
year = "1989",
doi = "10.3109/02841868909111247",
language = "English",
volume = "28",
pages = "199--201",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Management of malignant lymphoma in the elderly an eortc retrospective evaluation

AU - Tirelli, U.

PY - 1989

Y1 - 1989

N2 - A retrospective Eortc study was carried out in order to evaluate the incidence, clinico-pathoiogical findings and outcome of non-Hodgkin lymphoma and Hodgkin's disease in patients 70 years of age or older. A significant proportion of non-Hodgkin lymphoma, mostly with high-intermediate grade of malignancy occurs in these patients. Aggressive treatment, in particular chemotherapy with 3 drugs or more administered to elderly patients 70 years or older, median age 77 years, is associated with significant lethal and severe toxicity. Prospective randomized studies are clearly needed in order to evaluate the activity and the toxicity of intensive chemotherapy regimens specifically devised for patients aged 70 years or older with unfavourable non-Hodgkin lymphoma. Hodgkin's disease is unfrequently (5% seen in patients 70 years of age or older. Mixed cellularity, B symptoms and stage III and IV account for 50, 47 and 47% of the cases respectively. Aggressive treatment is not associated with an increased lethal and severe toxicity compared with conservative treatment although 1 patient died of bone marrow toxicity after MOPP. Survival of patients 70 years or more with Hodgkin's disease seen in 1984 seems shorter than that in younger patients, especially due to high incidence of unfavourable prognostic factors, such as B symptoms and advanced stages.

AB - A retrospective Eortc study was carried out in order to evaluate the incidence, clinico-pathoiogical findings and outcome of non-Hodgkin lymphoma and Hodgkin's disease in patients 70 years of age or older. A significant proportion of non-Hodgkin lymphoma, mostly with high-intermediate grade of malignancy occurs in these patients. Aggressive treatment, in particular chemotherapy with 3 drugs or more administered to elderly patients 70 years or older, median age 77 years, is associated with significant lethal and severe toxicity. Prospective randomized studies are clearly needed in order to evaluate the activity and the toxicity of intensive chemotherapy regimens specifically devised for patients aged 70 years or older with unfavourable non-Hodgkin lymphoma. Hodgkin's disease is unfrequently (5% seen in patients 70 years of age or older. Mixed cellularity, B symptoms and stage III and IV account for 50, 47 and 47% of the cases respectively. Aggressive treatment is not associated with an increased lethal and severe toxicity compared with conservative treatment although 1 patient died of bone marrow toxicity after MOPP. Survival of patients 70 years or more with Hodgkin's disease seen in 1984 seems shorter than that in younger patients, especially due to high incidence of unfavourable prognostic factors, such as B symptoms and advanced stages.

KW - Hodgkin's disease

KW - Non-Hodgkin lymphoma

KW - Old patients

UR - http://www.scopus.com/inward/record.url?scp=0024390504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024390504&partnerID=8YFLogxK

U2 - 10.3109/02841868909111247

DO - 10.3109/02841868909111247

M3 - Article

C2 - 2736109

AN - SCOPUS:0024390504

VL - 28

SP - 199

EP - 201

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

IS - 2

ER -